UVIEY
Dead / Abandoned — Abandoned — no statement of use filed (as of 20 Jul 2020)
What this means for you
This application is over — abandoned 20 Jul 2020. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87250560
- Mark type
- Stylized text
- Filed
- 29 Nov 2016
- Published for opposition
- 18 Apr 2017
- Abandoned
- 20 Jul 2020
- Attorney of record
- Jenevieve Maerker, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of ocular diseases and conditions, namely, uveitis, retinal vein occlusion, macular edema, macular disease, retinal disease, and glaucoma; pharmaceutical preparations for the treatment of ocular diseases and conditions, namely, uveitis, retinal vein occlusion, macular edema, macular disease, age-related macualr degeneration, retinal disease, and glaucoma
- Class 010 — Medical apparatus: Sustained drug delivery systems for ocular drugs
Owner
- EYEPOINT PHARMACEUTICALS US, INC., WATERTOWN, MA, US
- pSivida US, Inc., Watertown, MA, US
- pSivida US, Inc., Watertown, MA, US
Prosecution history
- 20 Jul 2020 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 20 Jul 2020 — ABANDONMENT - NO USE STATEMENT FILED
- 09 Oct 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Oct 2019 — SOU EXTENSION 5 GRANTED
- 03 Oct 2019 — SOU EXTENSION 5 FILED
- 08 Oct 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Oct 2019 — SOU TEAS EXTENSION RECEIVED
- 11 Jun 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jun 2019 — SOU EXTENSION 4 GRANTED
- 07 Jun 2019 — SOU EXTENSION 4 FILED
- 07 Jun 2019 — SOU TEAS EXTENSION RECEIVED
- 13 Nov 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Nov 2018 — SOU EXTENSION 3 GRANTED
- 09 Nov 2018 — SOU EXTENSION 3 FILED
- 09 Nov 2018 — SOU TEAS EXTENSION RECEIVED